0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microneedle Drug Delivery Systems Market Research Report 2026
Published Date: 2026-03-06
|
Report Code: QYRE-Auto-19P2408
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Microneedle Drug Delivery Systems Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Microneedle Drug Delivery Systems Market Research Report 2026

Code: QYRE-Auto-19P2408
Report
2026-03-06
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Microneedle Drug Delivery Systems Market Size

The global Microneedle Drug Delivery Systems market was valued at US$ 570 million in 2025 and is anticipated to reach US$ 1518 million by 2032, at a CAGR of 15.2% from 2026 to 2032.

Microneedle Drug Delivery Systems Market

Microneedle Drug Delivery Systems Market

Microneedle Drug Delivery Systems represent an innovative and painless drug administration technology that delivers medication precisely through micron-scale needles penetrating the skin’s outer layer. Combining micro-nanofabrication and controlled drug release technologies, these systems efficiently deliver vaccines, biologics, small molecule drugs, and more, significantly enhancing drug bioavailability and patient compliance. Compared to conventional injections, microneedle systems reduce pain and the risk of cross-contamination, enabling self-administration and large-scale immunization campaigns. With the rise of personalized medicine and smart healthcare devices, microneedle drug delivery systems show vast potential in chronic disease management, vaccination, and aesthetic medicine, positioning themselves as a key driver of medical innovation.
The microneedle drug delivery systems market benefits from the dual drivers of rising global healthcare demands and technological advancements. The surge in vaccine administration, especially driven by public health initiatives and immunization programs, accelerates the adoption of painless and efficient delivery technologies. Pharmaceutical companies and medical device manufacturers increase R&D investments to diversify products and expand applications. Policy support for innovative drug delivery technologies and patient preference for non-invasive treatments inject strong growth momentum. Additionally, penetration into emerging fields like chronic disease management and aesthetic medicine significantly broadens market potential.Despite promising prospects, microneedle drug delivery systems face multiple challenges. Technical complexity and high manufacturing costs limit large-scale commercialization. Compatibility issues between drugs and materials, as well as stability in delivery efficiency and dosage control, require further optimization. Regulatory approval processes are lengthy, and inconsistent standards across countries increase difficulties in global product rollout. Rising market concerns over safety and long-term efficacy demand continuous improvements in quality control and clinical validation. Education and patient acceptance also critically affect market penetration.Downstream demand is moving toward diversification and personalization. With the development of digital health and telemedicine, microneedle systems increasingly integrate intelligent monitoring and data analytics to enhance treatment precision and patient experience. The rapid delivery needs of vaccines and biologics drive innovations in logistics and supply chain management. In chronic disease management, microneedle systems offer convenient self-administration and efficacy monitoring. The aesthetic medicine market’s ongoing demand for safe and painless minimally invasive solutions propels product innovation and market expansion. Overall, downstream demand is evolving from single delivery functions to integrated health management platforms.
This report delivers a comprehensive overview of the global Microneedle Drug Delivery Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microneedle Drug Delivery Systems. The Microneedle Drug Delivery Systems market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microneedle Drug Delivery Systems market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microneedle Drug Delivery Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Microneedle Drug Delivery Systems Market Report

Report Metric Details
Report Name Microneedle Drug Delivery Systems Market
Accounted market size in 2025 US$ 570 million
Forecasted market size in 2032 US$ 1518 million
CAGR 15.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology
Segment by Application
  • Drug Delivery
  • Vaccine Delivery
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Inc, Vaxxas, Lohmann Therapie-Systeme AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Microneedle Drug Delivery Systems companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Microneedle Drug Delivery Systems Market growing?

Ans: The Microneedle Drug Delivery Systems Market witnessing a CAGR of 15.2% during the forecast period 2026-2032.

What is the Microneedle Drug Delivery Systems Market size in 2032?

Ans: The Microneedle Drug Delivery Systems Market size in 2032 will be US$ 1518 million.

Who are the main players in the Microneedle Drug Delivery Systems Market report?

Ans: The main players in the Microneedle Drug Delivery Systems Market are KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Inc, Vaxxas, Lohmann Therapie-Systeme AG

What are the Application segmentation covered in the Microneedle Drug Delivery Systems Market report?

Ans: The Applications covered in the Microneedle Drug Delivery Systems Market report are Drug Delivery, Vaccine Delivery

What are the Type segmentation covered in the Microneedle Drug Delivery Systems Market report?

Ans: The Types covered in the Microneedle Drug Delivery Systems Market report are Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microneedle Drug Delivery Systems Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Hollow Microneedle Technology
1.2.3 Solid Microneedle Technology
1.2.4 Dissolving Microneedles Technology
1.3 Market by Application
1.3.1 Global Microneedle Drug Delivery Systems Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Drug Delivery
1.3.3 Vaccine Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microneedle Drug Delivery Systems Market Perspective (2021–2032)
2.2 Global Microneedle Drug Delivery Systems Growth Trends by Region
2.2.1 Global Microneedle Drug Delivery Systems Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microneedle Drug Delivery Systems Historic Market Size by Region (2021–2026)
2.2.3 Microneedle Drug Delivery Systems Forecasted Market Size by Region (2027–2032)
2.3 Microneedle Drug Delivery Systems Market Dynamics
2.3.1 Microneedle Drug Delivery Systems Industry Trends
2.3.2 Microneedle Drug Delivery Systems Market Drivers
2.3.3 Microneedle Drug Delivery Systems Market Challenges
2.3.4 Microneedle Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microneedle Drug Delivery Systems Players by Revenue
3.1.1 Global Top Microneedle Drug Delivery Systems Players by Revenue (2021–2026)
3.1.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2021–2026)
3.2 Global Top Microneedle Drug Delivery Systems Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microneedle Drug Delivery Systems Revenue
3.4 Global Microneedle Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Microneedle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microneedle Drug Delivery Systems Revenue in 2025
3.5 Global Key Players of Microneedle Drug Delivery Systems Head Offices and Areas Served
3.6 Global Key Players of Microneedle Drug Delivery Systems, Products and Applications
3.7 Global Key Players of Microneedle Drug Delivery Systems, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microneedle Drug Delivery Systems Breakdown Data by Type
4.1 Global Microneedle Drug Delivery Systems Historic Market Size by Type (2021–2026)
4.2 Global Microneedle Drug Delivery Systems Forecasted Market Size by Type (2027–2032)
5 Microneedle Drug Delivery Systems Breakdown Data by Application
5.1 Global Microneedle Drug Delivery Systems Historic Market Size by Application (2021–2026)
5.2 Global Microneedle Drug Delivery Systems Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microneedle Drug Delivery Systems Market Size (2021–2032)
6.2 North America Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microneedle Drug Delivery Systems Market Size by Country (2021–2026)
6.4 North America Microneedle Drug Delivery Systems Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microneedle Drug Delivery Systems Market Size (2021–2032)
7.2 Europe Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microneedle Drug Delivery Systems Market Size by Country (2021–2026)
7.4 Europe Microneedle Drug Delivery Systems Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microneedle Drug Delivery Systems Market Size (2021–2032)
8.2 Asia-Pacific Microneedle Drug Delivery Systems Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microneedle Drug Delivery Systems Market Size by Region (2021–2026)
8.4 Asia-Pacific Microneedle Drug Delivery Systems Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microneedle Drug Delivery Systems Market Size (2021–2032)
9.2 Latin America Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microneedle Drug Delivery Systems Market Size by Country (2021–2026)
9.4 Latin America Microneedle Drug Delivery Systems Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microneedle Drug Delivery Systems Market Size (2021–2032)
10.2 Middle East & Africa Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country (2021–2026)
10.4 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KINDEVA
11.1.1 KINDEVA Company Details
11.1.2 KINDEVA Business Overview
11.1.3 KINDEVA Microneedle Drug Delivery Systems Introduction
11.1.4 KINDEVA Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.1.5 KINDEVA Recent Development
11.2 Zosano Pharma
11.2.1 Zosano Pharma Company Details
11.2.2 Zosano Pharma Business Overview
11.2.3 Zosano Pharma Microneedle Drug Delivery Systems Introduction
11.2.4 Zosano Pharma Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.2.5 Zosano Pharma Recent Development
11.3 Becton-Dickinson(BD)Technologies
11.3.1 Becton-Dickinson(BD)Technologies Company Details
11.3.2 Becton-Dickinson(BD)Technologies Business Overview
11.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Introduction
11.3.4 Becton-Dickinson(BD)Technologies Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.3.5 Becton-Dickinson(BD)Technologies Recent Development
11.4 Nanopass Technologies
11.4.1 Nanopass Technologies Company Details
11.4.2 Nanopass Technologies Business Overview
11.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Introduction
11.4.4 Nanopass Technologies Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.4.5 Nanopass Technologies Recent Development
11.5 Corium
11.5.1 Corium Company Details
11.5.2 Corium Business Overview
11.5.3 Corium Microneedle Drug Delivery Systems Introduction
11.5.4 Corium Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.5.5 Corium Recent Development
11.6 Valeritas
11.6.1 Valeritas Company Details
11.6.2 Valeritas Business Overview
11.6.3 Valeritas Microneedle Drug Delivery Systems Introduction
11.6.4 Valeritas Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.6.5 Valeritas Recent Development
11.7 Nitto
11.7.1 Nitto Company Details
11.7.2 Nitto Business Overview
11.7.3 Nitto Microneedle Drug Delivery Systems Introduction
11.7.4 Nitto Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.7.5 Nitto Recent Development
11.8 Microdermics
11.8.1 Microdermics Company Details
11.8.2 Microdermics Business Overview
11.8.3 Microdermics Microneedle Drug Delivery Systems Introduction
11.8.4 Microdermics Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.8.5 Microdermics Recent Development
11.9 TheraJect, Inc
11.9.1 TheraJect, Inc Company Details
11.9.2 TheraJect, Inc Business Overview
11.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Introduction
11.9.4 TheraJect, Inc Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.9.5 TheraJect, Inc Recent Development
11.10 Vaxxas
11.10.1 Vaxxas Company Details
11.10.2 Vaxxas Business Overview
11.10.3 Vaxxas Microneedle Drug Delivery Systems Introduction
11.10.4 Vaxxas Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.10.5 Vaxxas Recent Development
11.11 Lohmann Therapie-Systeme AG
11.11.1 Lohmann Therapie-Systeme AG Company Details
11.11.2 Lohmann Therapie-Systeme AG Business Overview
11.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Introduction
11.11.4 Lohmann Therapie-Systeme AG Revenue in Microneedle Drug Delivery Systems Business (2021–2026)
11.11.5 Lohmann Therapie-Systeme AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Microneedle Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Hollow Microneedle Technology
 Table 3. Key Players of Solid Microneedle Technology
 Table 4. Key Players of Dissolving Microneedles Technology
 Table 5. Global Microneedle Drug Delivery Systems Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Microneedle Drug Delivery Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Microneedle Drug Delivery Systems Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Microneedle Drug Delivery Systems Market Share by Region (2021–2026)
 Table 9. Global Microneedle Drug Delivery Systems Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Microneedle Drug Delivery Systems Market Share by Region (2027–2032)
 Table 11. Microneedle Drug Delivery Systems Market Trends
 Table 12. Microneedle Drug Delivery Systems Market Drivers
 Table 13. Microneedle Drug Delivery Systems Market Challenges
 Table 14. Microneedle Drug Delivery Systems Market Restraints
 Table 15. Global Microneedle Drug Delivery Systems Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Microneedle Drug Delivery Systems Market Share by Players (2021–2026)
 Table 17. Global Top Microneedle Drug Delivery Systems Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microneedle Drug Delivery Systems Revenue, 2025
 Table 18. Ranking of Global Top Microneedle Drug Delivery Systems Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Microneedle Drug Delivery Systems Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Microneedle Drug Delivery Systems, Headquarters and Area Served
 Table 21. Global Key Players of Microneedle Drug Delivery Systems, Products and Applications
 Table 22. Global Key Players of Microneedle Drug Delivery Systems, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Microneedle Drug Delivery Systems Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Microneedle Drug Delivery Systems Revenue Market Share by Type (2021–2026)
 Table 26. Global Microneedle Drug Delivery Systems Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Microneedle Drug Delivery Systems Revenue Market Share by Type (2027–2032)
 Table 28. Global Microneedle Drug Delivery Systems Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2021–2026)
 Table 30. Global Microneedle Drug Delivery Systems Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2027–2032)
 Table 32. North America Microneedle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Microneedle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Microneedle Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Microneedle Drug Delivery Systems Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Microneedle Drug Delivery Systems Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Microneedle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Microneedle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032
 Table 47. KINDEVA Company Details
 Table 48. KINDEVA Business Overview
 Table 49. KINDEVA Microneedle Drug Delivery Systems Product
 Table 50. KINDEVA Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 51. KINDEVA Recent Development
 Table 52. Zosano Pharma Company Details
 Table 53. Zosano Pharma Business Overview
 Table 54. Zosano Pharma Microneedle Drug Delivery Systems Product
 Table 55. Zosano Pharma Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 56. Zosano Pharma Recent Development
 Table 57. Becton-Dickinson(BD)Technologies Company Details
 Table 58. Becton-Dickinson(BD)Technologies Business Overview
 Table 59. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product
 Table 60. Becton-Dickinson(BD)Technologies Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 61. Becton-Dickinson(BD)Technologies Recent Development
 Table 62. Nanopass Technologies Company Details
 Table 63. Nanopass Technologies Business Overview
 Table 64. Nanopass Technologies Microneedle Drug Delivery Systems Product
 Table 65. Nanopass Technologies Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 66. Nanopass Technologies Recent Development
 Table 67. Corium Company Details
 Table 68. Corium Business Overview
 Table 69. Corium Microneedle Drug Delivery Systems Product
 Table 70. Corium Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 71. Corium Recent Development
 Table 72. Valeritas Company Details
 Table 73. Valeritas Business Overview
 Table 74. Valeritas Microneedle Drug Delivery Systems Product
 Table 75. Valeritas Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 76. Valeritas Recent Development
 Table 77. Nitto Company Details
 Table 78. Nitto Business Overview
 Table 79. Nitto Microneedle Drug Delivery Systems Product
 Table 80. Nitto Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 81. Nitto Recent Development
 Table 82. Microdermics Company Details
 Table 83. Microdermics Business Overview
 Table 84. Microdermics Microneedle Drug Delivery Systems Product
 Table 85. Microdermics Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 86. Microdermics Recent Development
 Table 87. TheraJect, Inc Company Details
 Table 88. TheraJect, Inc Business Overview
 Table 89. TheraJect, Inc Microneedle Drug Delivery Systems Product
 Table 90. TheraJect, Inc Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 91. TheraJect, Inc Recent Development
 Table 92. Vaxxas Company Details
 Table 93. Vaxxas Business Overview
 Table 94. Vaxxas Microneedle Drug Delivery Systems Product
 Table 95. Vaxxas Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 96. Vaxxas Recent Development
 Table 97. Lohmann Therapie-Systeme AG Company Details
 Table 98. Lohmann Therapie-Systeme AG Business Overview
 Table 99. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product
 Table 100. Lohmann Therapie-Systeme AG Revenue in Microneedle Drug Delivery Systems Business (US$ Million), 2021–2026
 Table 101. Lohmann Therapie-Systeme AG Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Microneedle Drug Delivery Systems Picture
 Figure 2. Global Microneedle Drug Delivery Systems Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Microneedle Drug Delivery Systems Market Share by Type: 2025 vs 2032
 Figure 4. Hollow Microneedle Technology Features
 Figure 5. Solid Microneedle Technology Features
 Figure 6. Dissolving Microneedles Technology Features
 Figure 7. Global Microneedle Drug Delivery Systems Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Microneedle Drug Delivery Systems Market Share by Application: 2025 vs 2032
 Figure 9. Drug Delivery Case Studies
 Figure 10. Vaccine Delivery Case Studies
 Figure 11. Microneedle Drug Delivery Systems Report Years Considered
 Figure 12. Global Microneedle Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Microneedle Drug Delivery Systems Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Microneedle Drug Delivery Systems Market Share by Region: 2025 vs 2032
 Figure 15. Global Microneedle Drug Delivery Systems Market Share by Players in 2025
 Figure 16. Global Microneedle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Microneedle Drug Delivery Systems Revenue in 2025
 Figure 18. North America Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Microneedle Drug Delivery Systems Market Share by Country (2021–2032)
 Figure 20. United States Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Microneedle Drug Delivery Systems Market Share by Country (2021–2032)
 Figure 24. Germany Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Microneedle Drug Delivery Systems Market Share by Region (2021–2032)
 Figure 32. China Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Microneedle Drug Delivery Systems Market Share by Country (2021–2032)
 Figure 40. Mexico Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Microneedle Drug Delivery Systems Market Share by Country (2021–2032)
 Figure 44. Israel Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Microneedle Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. KINDEVA Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 48. Zosano Pharma Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 49. Becton-Dickinson(BD)Technologies Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 50. Nanopass Technologies Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 51. Corium Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 52. Valeritas Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 53. Nitto Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 54. Microdermics Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 55. TheraJect, Inc Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 56. Vaxxas Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 57. Lohmann Therapie-Systeme AG Revenue Growth Rate in Microneedle Drug Delivery Systems Business (2021–2026)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS